EUVIMEDEUVIMED entdecken
Open Access

Dual role of Tropomyosin-R160 in thin filament regulation: Insights into phosphorylation-dependent cardiac relaxation and cardiomyopathy mechanisms

Meaghan E Barry, Michael J Rynkiewicz, Jian Wen, An-Yue Tu, Michael Regnier, William Lehman, Jeffrey R Moore

Archives of Biochemistry and Biophysics · 2025-06 · 768 · 110380

DOI: 10.1016/j.abb.2025.110380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025-06. Verfasst von Meaghan E Barry und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Massachusetts Lowell, Department of Biological Sciences, One University Ave, Lowell, MA 01854, USA. Hauptthemen laut MEDLINE: Tropomyosin, Cardiomyopathies, Actin Cytoskeleton. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAMS NIH HHS, American Heart Association-American Stroke Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

β-adrenergic stimulation causes cell signaling that targets modulation of calcium levels as well as sarcomeric proteins to increases contractility. PKA phosphorylation of serine residues 23 and 24 of troponin I reduces calcium sensitivity and promotes cardiac relaxation. Our protein-protein docking and molecular dynamics studies revealed that Tpm-R160 is adjacent to these phosphorylation sites. In addition, Tpm-R160 has been identified as a disease-causing mutation site. Here, we investigated Tpm-R160's role in thin filament regulation and its interaction with phosphorylated TnI. Using invitro motility assays, calcium sensitivity was quantified in reconstituted thin filaments containing various combinations of a phosphomimetic version of troponin I (TnI-S23/24D) and tropomyosin where the charge and potential for electrostatic interaction was removed by mutation of Tpm-R160 to a neutral alanine (Tpm-R160A). As expected, the phosphomimetic TnI (TnI-S23/24D) reduced calcium sensitivity in thin filaments with wild-type tropomyosin. However, the phosphorylation-like effect was diminished in the presence of the Tpm-R160A mutation. Notably, Tpm-R160A alone, when paired with wild-type TnI, also showed reduced calcium sensitivity, indicating that mutation of Tpm-R160 affects thin filament regulation in the absence of phosphorylation. Our findings indicate that Tpm-R160 has a dual role in thin filament regulation: (1)it is crucial for proper interaction between phosphorylated TnI and Tpm-R160 during adrenergic-induced cardiac relaxation, and (2) at the same time, the arginine residue itself is additionally required for maintenance of overall calcium sensitivity. These results provide key insight into the molecular defects underlying cardiomyopathy and a framework for development of therapeutic strategies targeting Tpm-R160 interactions. (249 words).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TropomyosinCardiomyopathiesActin CytoskeletonPhosphorylationCalciumAnimalsTroponin IHumansMolecular Dynamics Simulation

Stichwörter der Autor:innen

Adrenergic stimulationCardiac thin filamentCardiomyopathyPhosphorylationTropomyosinTroponin I

Substanzen

TropomyosinCalciumTroponin I

Autor:innen und Institutionen

  • University of Massachusetts Lowell, Department of Biological Sciences, One University Ave, Lowell, MA 01854, USA.
  • Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian & Avedisian School of Medicine, 700 Albany Street, Boston, MA, 02118, USA.
  • Department of Bioengineering, University of Washington, Box 355061, Seattle, WA, 98195-506, USA.
  • University of Massachusetts Lowell, Department of Biological Sciences, One University Ave, Lowell, MA 01854, USA. Electronic address: jeffrey_moore@uml.edu.

Förderung

  • NHLBI NIH HHS
  • NIAMS NIH HHS
  • American Heart Association-American Stroke Association
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • American Heart Association

Zitieren

APA

Barry, M. E., Rynkiewicz, M. J., Wen, J., Tu, A. Y., Regnier, M., Lehman, W., & Moore, J. R. (2025). Dual role of Tropomyosin-R160 in thin filament regulation: Insights into phosphorylation-dependent cardiac relaxation and cardiomyopathy mechanisms. Archives of Biochemistry and Biophysics, 768, 110380. https://doi.org/10.1016/j.abb.2025.110380

Vancouver

Barry ME, Rynkiewicz MJ, Wen J, Tu AY, Regnier M, Lehman W, et al. Dual role of Tropomyosin-R160 in thin filament regulation: Insights into phosphorylation-dependent cardiac relaxation and cardiomyopathy mechanisms. Archives of Biochemistry and Biophysics. 2025;768:110380. doi:10.1016/j.abb.2025.110380

BibTeX
@article{Barry2025,
  author = {Barry, Meaghan E and Rynkiewicz, Michael J and Wen, Jian and Tu, An-Yue and Regnier, Michael and Lehman, William and Moore, Jeffrey R},
  title = {Dual role of Tropomyosin-R160 in thin filament regulation: Insights into phosphorylation-dependent cardiac relaxation and cardiomyopathy mechanisms},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2025},
  volume = {768},
  pages = {110380},
  doi = {10.1016/j.abb.2025.110380}
}
Kostenlos starten →